The store will not work correctly when cookies are disabled.
(3-fluorophenyl)(2-hydroxy-4,6-dimethoxy-3-(morpholinomethyl)phenyl)methanone
ID: ALA1091435
PubChem CID: 46884376
Max Phase: Preclinical
Molecular Formula: C20H22FNO5
Molecular Weight: 375.40
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc(OC)c(C(=O)c2cccc(F)c2)c(O)c1CN1CCOCC1
Standard InChI: InChI=1S/C20H22FNO5/c1-25-16-11-17(26-2)18(19(23)13-4-3-5-14(21)10-13)20(24)15(16)12-22-6-8-27-9-7-22/h3-5,10-11,24H,6-9,12H2,1-2H3
Standard InChI Key: TXYUGGSDJITCKY-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
3.0277 -22.8666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0266 -23.6940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7414 -24.1069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4578 -23.6935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4550 -22.8630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7396 -22.4539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3118 -24.1059 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5976 -23.6929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7371 -21.6289 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4504 -21.2142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1730 -24.1049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1679 -22.4478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8839 -22.8576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1648 -21.6228 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8837 -23.6803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5988 -24.0900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3127 -23.6747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3070 -22.8455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5912 -22.4395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7412 -24.9319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0266 -25.3442 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3134 -24.9331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6010 -25.3419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5965 -26.1673 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3107 -26.5822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0294 -26.1717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0184 -22.4278 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
12 14 2 0
2 7 1 0
13 15 2 0
3 4 2 0
15 16 1 0
7 8 1 0
16 17 2 0
17 18 1 0
6 9 1 0
18 19 2 0
19 13 1 0
4 5 1 0
3 20 1 0
9 10 1 0
20 21 1 0
21 22 1 0
2 3 1 0
4 11 1 0
5 6 2 0
5 12 1 0
6 1 1 0
21 26 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
12 13 1 0
18 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 375.40 | Molecular Weight (Monoisotopic): 375.1482 | AlogP: 2.61 | #Rotatable Bonds: 6 |
Polar Surface Area: 68.23 | Molecular Species: ACID | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 6.46 | CX Basic pKa: 5.24 | CX LogP: 3.07 | CX LogD: 2.30 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.78 | Np Likeness Score: -0.60 |
References
1. Bandgar BP, Patil SA, Totre JV, Korbad BL, Gacche RN, Hote BS, Jalde SS, Chavan HV.. (2010) Synthesis and biological evaluation of nitrogen-containing benzophenone analogues as TNF-alpha and IL-6 inhibitors with antioxidant activity., 20 (7): [PMID:20207143] [10.1016/j.bmcl.2010.02.001] |